[{"Assets_0_Q1_USD":"1444500000.0","CIK":"899923","CommonStockSharesConverted_0_Q1_shares":"75200000.0","CommonStockSharesOutstanding_0_Q1_shares":"75200000.0","Country":"United States","EarningsPerShareBasic_1_Q1_USD":"-0.2","Industry":"Biotechnology: In Vitro & In Vivo Diagnostic Substances","Market":"NASDAQ","Market Cap":"1850258412.0","MinorityInterest_0_Q1_USD":"0.0","NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":"-59300000.0","NetIncomeLoss_1_Q1_USD":"-15200000.0","OfficialName":"Myriad Genetics Inc. Common Stock","ProfitLoss_1_Q1_USD":"-15200000.0","RevenuesConverted_1_Q1_USD":"145200000.0","SP500":null,"Sector":"Health Care","StockholdersEquityConverted_0_Q1_USD":"909300000.0","StockholdersEquity_0_Q1_USD":"909300000.0","Ticker":"MYGN","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":"74700000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":"74700000.0","filed":"20201109","footnote":null,"form":"10-Q","fp":"Q1","fy":"2021.0","name":"MYRIAD GENETICS INC","period":"20200930","qtrs":"1","uom":"USD"}]